Cannara Biotech Inc. (
CSE: LOVE,
OTCQB: CNBTF,
Forum) today released its second quarter financial results for the Company’s fiscal 2019. Among the highlights in the announcement:
- Commenced trading on the Canadian Securities Exchange (CSE) as of January 14, 2019
- Extended its Phase One build-out from 130,000 to 170,000 square feet
- Entered the U.S. hemp-CDB market via a subsidiary
As part of Cannara’s expansion of its cultivation facility, the Company has invested more than $10.5 million. With over $37 million raised in financings, Cannara’s operations remain well-financed. Looking forward, the Company has a letter of intent (LOI) in place with a Quebec microbrewery to develop cannabis-infused beverages.
Further details are available
here. Cannara Biotech was recently in the news on April 8, 2019 when the Company announced
adding a new director.
FULL DISCLOSURE: Cannara Biotech Inc. is a paid client of Stockhouse Publishing.